Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study

Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study

Abstract Background Mandatory trial registration, and later results reporting, were proposed to mitigate selective clinical trial publication and outcome reporting. The Food and Drug Administration (FDA) Amendments Act (FDAAA) was enacted by Congress on September 27, 2007, requiring the registration...

Full description

Bibliographic Details
Main Authors: Constance X. Zou, Jessica E. Becker, Adam T. Phillips, James M. Garritano, Harlan M. Krumholz, Jennifer E. Miller, Joseph S. Ross
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Trials
Subjects:
FDAAA
ClinicalTrials.gov
Clinical trial registration
Clinical trial results
Selective publication
Publication bias
Online Access:http://link.springer.com/article/10.1186/s13063-018-2957-0

Internet

http://link.springer.com/article/10.1186/s13063-018-2957-0

Similar Items